Congress trades in BioCryst Pharmaceuticals (BCRX)
Healthcare · Biotechnology
2 members of Congress have disclosed 4 trades in BioCryst Pharmaceuticals (BCRX) since 2023: 3 buys and 1 sale. The most recent was disclosed on Sep 7, 2026.
- Trades disclosed
- 4
- Members trading
- 2
- Buys / sells
- 3 / 1
- Reported value
- $4K–$60K
Who traded BCRX
- Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)2 buys · 0 sales20Sep 7, 2026
- Rep. Josh Gottheimer (D-NJ-5)1 buy · 1 sale11Nov 11, 2023
All trades
- Sep 7, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Jul 10, 2026 · disclosed Sep 7, 2026 · filed 59 days later
- Dec 15, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Nov 13, 2025 · disclosed Dec 15, 2025
- Nov 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Oct 16, 2023 · disclosed Nov 11, 2023 · Joint
- Oct 15, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold (full) BioCryst Pharmaceuticals BCRX
$1K–$15K · Traded Sep 15, 2023 · disclosed Oct 15, 2023 · Joint
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.